Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

Neuroprotective dimethyl fumarate synergizes with immunomodulatory interferon beta to provide enhanced axon protection in autoimmune neuroinflammation.
Dynamics of B-Cell Populations in CSF and Blood in Patients Treated with a Combination of Rituximab and Mitoxantrone.
Distinction between MOG antibody-positive and AQP4 antibody-positive NMO spectrum disorders.
Cortical demyelination is prominent in the murine cuprizone model and is strain-dependent.
MS disease activity in RESTORE: A randomized 24-week natalizumab treatment interruption study.
Oral BG-12 (dimethyl fumarate) significantly reduced multiple sclerosis (MS) relapses and disability progression in DEFINE Phase 3 clinical trial
Comparative efficacy of switching to natalizumab in active multiple sclerosis.
Cuprizone demyelination of the corpus callosum in mice correlates with altered social interaction and impaired bilateral sensorimotor coordination.
Environmental factors in multiple sclerosis: Epstein-Barr virus, vitamin D, and cigarette smoking.
Clinically isolated syndrome - Rethinking the diagnosis.
Optical coherence tomography reflects brain atrophy in MS: A four year study.
Firategrast: natalizumab in a pill?
Suppressed RNA-Polymerase 1 Pathway Is Associated with Benign Multiple Sclerosis.
Teriflunomide reduces behavioral, electrophysiological, and histopathological deficits in the Dark Agouti rat model of experimental autoimmune encephalomyelitis.
Effects of dimethyl fumarate on neuroprotection and immunomodulation.
MS clinical trials: what can subgroup analyses teach us?
Status spongiosus of CNS and hepatic changes induced by cuprizone (biscyclohexanone oxalyldihydrazone).
Relapses Requiring Intravenous Steroid Use and Multiple-Sclerosis-Related Hospitalizations: Integrated Analysis of the Delayed-Release Dimethyl Fumarate Phase III Studies.
Clinical efficacy of BG-12 (dimethyl fumarate) in patients with relapsing-remitting multiple sclerosis: subgroup analyses of the DEFINE study.
Exposure levels of anti-LINGO-1 Li81 antibody in the central nervous system and dose-efficacy relationships in rat spinal cord remyelination models after systemic administration.
Comparative effectiveness of fingolimod versus interferons or glatiramer acetate for relapse rates in multiple sclerosis: a retrospective US claims database analysis.
Cuprizone treatment induces demyelination and astrocytosis in the mouse hippocampus.
Interferon-β therapy against EAE is effective only when development of the disease depends on the NLRP3 inflammasome.
Management of worsening multiple sclerosis with mitoxantrone: a review.
Delta-9-tetrahydrocannabinol/cannabidiol (sativex(®)): a review of its use in patients with moderate to severe spasticity due to multiple sclerosis.

Pages